Aethlon Medical Announces Pricing of $4.5 Million Public Offering
(NASDAQ:AEMD) SAN DIEGO, Sept. 4, 2025 /PRNewswire/ -- Aethlon Medical, Inc. ("Aethlon" or the "Company") (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cance...
Will the use of proceedsâas outlined by managementâenhance the companyâs drug pipeline and potentially drive future earnings growth?
What pricing terms (e.g., discount to market, lockâup period) were set for the offering, and how might they impact existing shareholders?
How will the $4.5âŻmillion public offering affect Aethlonâs cash runway and future financing needs?
8 days ago